Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
Study NCT ID:
NCT00428220
Status:
COMPLETED
Last Update Posted:
2019-06-27
First Post:
2007-01-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-26
First Submit QC Date:
None
Study First Post Date:
2007-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-26
Results First Submit QC Date:
None
Results First Post Date:
2015-11-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-20
Last Update Post Date:
2019-06-27
Last Update Post Date Type:
ACTUAL